Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Multi Cap Fund median (62 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 03 Apr 2006 – 20 Aug 2026. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one. Nifty 500 history starts 25 Jul 2016, so that benchmark is not plotted over this window — pick a shorter range to see it.
View as table
| Date | Nippon India Multi Cap Fund |
|---|---|
| 03 Apr 2006 | ₹100.00 |
| 14 Dec 2007 | ₹163.36 |
| 26 Aug 2009 | ₹121.55 |
| 08 May 2011 | ₹188.05 |
| 17 Jan 2013 | ₹236.17 |
| 30 Sep 2014 | ₹350.51 |
| 11 Jun 2016 | ₹369.35 |
| 21 Feb 2018 | ₹491.76 |
| 04 Nov 2019 | ₹512.12 |
| 16 Jul 2021 | ₹678.10 |
| 28 Mar 2023 | ₹837.64 |
| 08 Dec 2024 | ₹1584.20 |
| 20 Aug 2026 | ₹1613.01 |
| Metric | Nippon India · Regular · Bonus NAV ₹305.09 Very High risk ★★★☆☆ | Category median Multi Cap Fund · 62 funds |
|---|---|---|
| +0.64% | +6.47% | |
| +14.66% | +14.36% | |
| +18.55% | +12.42% | |
| +15.02% | +13.76% | |
| +14.62% | +13.42% | |
| +15.07% | — | |
| +16.80% | +16.73% | |
| +16.04% | +14.15% | |
| +14.87% | +13.80% | |
| Risk | ||
| 14.46% | 15.23% | |
| 0.56 | 0.46 | |
| 0.76 | 0.60 | |
| -64.59% | -20.75% | |
| Nifty 500 | — | |
| +2.04% | +1.86% | |
| 0.94 | 1.01 | |
| 103.5% | 106.4% | |
| 94.4% | 97.5% | |
| 1.60% | 2.19% | |
| ₹52,649Cr | ₹3,760Cr | |
| Up to 1.00% | — | |
| None | — | |
| ₹100 | — | |
| ₹100 | — | |
| 89% | 54% | |
| Ashutosh Bhargava | — | |
| 03 Apr 2006 | — | |
| 120 | — | |
| 31.6% | — | |
| 0.6% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.